Access cutting-edge cancer treatment through this clinical trial at a research site in Little Rock. Study-provided care at no cost to qualified participants.
Access cancer specialists in Little Rock at no cost
This study follows strict safety protocols and ethical guidelines
All study-related cancer treatment provided free
RPL-001-16 is a Phase 1/2, open label, dose escalation and expansion clinical study of RP1 alone and in combination with nivolumab in adult subjects with advanced and/or refractory solid tumors, to determine the maximum tolerated dose (MTD) and recommended Phase 2 dose (RP2D), as well as to evaluate preliminary efficacy.
Sponsor: Replimune Inc.
Check if you qualify for this cancer clinical trial in Little Rock, AR
If you're searching for cancer treatment options in Little Rock, AR, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Little Rock research site is actively enrolling participants for this clinical trial. You'll receive care from experienced cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.